Antibody-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Infectivity Is Determined by the Structure of gp120 and Depends on Modulation of the gp120-CCR5 Interaction

Por Guillon, Christophe, Schutten, Martin, Boers, Patrick H. M., Gruters, Rob A., Osterhaus, Albert D. M. E.
Publicado em 2002

SIVdrl detection in captive mandrills: are mandrills infected with a third strain of simian immunodeficiency virus?

Por van der Kuyl, Antoinette C, van den Burg, Remco, Hoyer, Mark J, Gruters, Rob A, Osterhaus, Albert DME, Berkhout, Ben
Publicado em 2004

Coreceptor Usage of Human Immunodeficiency Virus Type 2 Primary Isolates and Biological Clones Is Broad and Does Not Correlate with Their Syncytium-Inducing Capacities

Por Guillon, Christophe, van der Ende, Marchina E., Boers, Patrick H. M., Gruters, Rob A., Schutten, Martin, Osterhaus, Albert D. M. E.
Publicado em 1998

Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment

Por van den Ham, Henk-Jan, Cooper, Jason D., Tomasik, Jakub, Bahn, Sabine, Aerts, Joeri L., Osterhaus, Albert D. M. E., Gruters, Rob A., Andeweg, Arno C.
Publicado no PLoS One (2018)

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stabl...

Por de Jong, Wesley, Aerts, Joeri, Allard, Sabine, Brander, Christian, Buyze, Jozefien, Florence, Eric, van Gorp, Eric, Vanham, Guido, Leal, Lorna, Mothe, Beatriz, Thielemans, Kris, Plana, Montse, Garcia, Félipe, Gruters, Rob
Publicado no Trials (2019)

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patie...

Por de Jong, Wesley, Aerts, Joeri, Allard, Sabine, Brander, Christian, Buyze, Jozefien, Florence, Eric, van Gorp, Eric, Vanham, Guido, Leal, Lorna, Mothe, Beatriz, Thielemans, Kris, Plana, Montse, Garcia, Félipe, Gruters, Rob
Publicado no Trials (2019)

Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4(+) T Cell Counts in Viremic HIV-2 Infection

Por Khalid, Mohammad, Yu, Hangxing, Sauter, Daniel, Usmani, Shariq M., Schmokel, Jan, Feldman, Jerome, Gruters, Rob A., van der Ende, Marchina E., Geyer, Matthias, Rowland-Jones, Sarah, Osterhaus, Albert D., Kirchhoff, Frank
Publicado em 2012

The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals

Por Yu, Hangxing, Usmani, Shariq M, Borch, Alexandra, Krämer, Julia, Stürzel, Christina M, Khalid, Mohammad, Li, Xuehua, Krnavek, Daniela, van der Ende, Marchina E, Osterhaus, Albert D, Gruters, Rob A, Kirchhoff, Frank
Publicado em 2013

Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots

Por Meesters, Roland J. W., van Kampen, Jeroen J. A., Reedijk, Mariska L., Scheuer, Rachel D., Dekker, Lennard J. M., Burger, David M., Hartwig, Nico G., Osterhaus, Albert D. M. E., Luider, Theo M., Gruters, Rob A.
Publicado em 2010

von Willebrand Factor is elevated in HIV patients with a history of thrombosis

Por van den Dries, Lennert W. J., Gruters, Rob A., Hövels–van der Borden, Sascha B. C., Kruip, Marieke J. H. A., de Maat, Moniek P. M., van Gorp, Eric C. M., van der Ende, Marchina E.
Publicado no Front Microbiol (2015)

Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinic

Por Hooff, Gero P., Meesters, Roland J. W., van Kampen, Jeroen J. A., van Huizen, Nick A., Koch, Birgit, Al Hadithy, Asmar F. Y., van Gelder, Teun, Osterhaus, Albert D. M. E., Gruters, Rob A., Luider, Theo M.
Publicado em 2011

Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry

Por van Kampen, Jeroen J. A., Reedijk, Mariska L., Burgers, Peter C., Dekker, Lennard J. M., Hartwig, Nico G., van der Ende, Ineke E., de Groot, Ronald, Osterhaus, Albert D. M. E., Burger, David M., Luider, Theo M., Gruters, Rob A.
Publicado em 2010

Correction: Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry

Por van Kampen, Jeroen J. A., Reedijk, Mariska L., Burgers, Peter C., Dekker, Lennard J. M., Hartwig, Nico G., van der Ende, Ineke E., de Groot, Ronald, Osterhaus, Albert D. M. E., Burger, David M., Luider, Theo M., Gruters, Rob A.
Publicado em 2010

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix †

Por de Jong, Wesley, Leal, Lorna, Buyze, Jozefien, Pannus, Pieter, Guardo, Alberto, Salgado, Maria, Mothe, Beatriz, Molto, Jose, Moron-Lopez, Sara, Gálvez, Cristina, Florence, Eric, Vanham, Guido, van Gorp, Eric, Brander, Christian, Allard, Sabine, Thielemans, Kris, Martinez-Picado, Javier, Plana, Montserrat, García, Felipe, Gruters, Rob A.
Publicado no Vaccines (Basel) (2019)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

Por Leal, Lorna, Guardo, Alberto C., Morón-López, Sara, Salgado, Maria, Mothe, Beatriz, Heirman, Carlo, Pannus, Pieter, Vanham, Guido, van den Ham, Henk Jan, Gruters, Rob, Andeweg, Arno, Van Meirvenne, Sonja, Pich, Judit, Arnaiz, Joan Albert, Gatell, Josep M., Brander, Christian, Thielemans, Kris, Martínez-Picado, Javier, Plana, Montserrat, García, Felipe
Publicado no AIDS (2018)